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Available online 1 April 2014AbstractBackground: Urinary tract infections are a major public health problem in developing countries. The spread of microbial drug resistance has
become a global threat, challenging public health, and can result in increased illness and even lead to death in the chronic stages of infection.
There is a desire to identify and exploit newer, ecologically friendly antimicrobial agents from natural sources to overcome this problem.
Purpose: This work was carried out to investigate the antibacterial potential of Callistemon lanceolatus DC seed extracts against 11 isolates of
uropathogenic bacteria.
Methods: Bacteria isolated from urine samples were collected from the Krishna Rajendra Hospital, Mysore, India and were subjected to
biochemical tests followed by standard procedures for bacterial identification. The uropathogens were then tested for susceptibility to antibiotics
using an assay following the KirbyeBauer method. Phytochemical analyses of seed extracts of C. lanceolatus DC were carried out to identify
the various phytocomponents. Antibacterial activity against 11 uropathogenic isolates using petroleum ether, chloroform, ethyl acetate, and
methanol seed extracts of C. lanceolatus were carried out following the KirbyeBauer disc diffusion method.
Results: The identities of the bacteria were confirmed by the biochemical tests. Antibiogram assays showed the sensitivity of the pathogens
towards the test antibiotics. The phytochemical analyses showed the presence of carbohydrates, saponins, and phytosterols in all the test solvent
extracts; alkaloids, tannins, and amino acids were absent from all the test solvent extracts. Tests to determine the antibacterial activity of seed
extracts of C. lanceolatus against 11 isolates of bacteria showed significant activity against Staphylococcus aureus in petroleum ether and
chloroform extracts; the ethyl acetate and methanol extracts showed significant activity against Proteus mirabilis. All the test solvent extracts
showed the least activity against Acinetobacter baumannii. Petroleum ether, ethyl acetate, and methanol extracts also showed the least activity
against Citrobacter freundii; only ethyl acetate showed moderate activity against Enterococcus faecalis. The methanol extract showed moderate
activity against Escherichia coli. Ethyl acetate and methanol extracts showed a moderate zone of inhibition against Klebsiella pneumoniae.
Conclusion: This study shows that C. lanceolatus has an inhibitory effect on uropathogenic bacteria. The antibacterial activity of this plant could
be exploited as a therapeutic agent for further investigation of the bioactive compounds responsible for antibacterial activity.
Copyright  2014, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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A urinary tract infection (UTI) occurs when microorgan-
isms reside and multiply within the urinary tract and cause an* Corresponding author. Herbal Drug Technological Laboratory, Department
of Studies in Microbiology, University of Mysore, Manasagangotri, Mysore
570 006, India.
E-mail address: satish.micro@gmail.com (S. Satish).
http://dx.doi.org/10.1016/j.jacme.2013.12.001
2211-5587/Copyright  2014, Taiwan Society of Emergency Medicine. Publishedinfection. About 95% of the microorganisms responsible for
such infections are bacteria, although fungi and viruses have
also been found to cause UTIs. Among the bacteria, Escher-
ichia coli is the predominant pathogen, causing about 80% of
all cases of UTI, followed by other species of bacteria such as
Staphylococcus, Klebsiella, Enterobacter, Proteus, and
Enterococcus.1 Guidelines vary, but typically a pure culture of
between 104 CFUs/mL and 106 CFUs/mL of urine is indicative
of a UTI.2 Common symptoms of UTIs include leukorrhea,by Elsevier Taiwan LLC. All rights reserved.
7K.S. Kavitha, S. Satish / Journal of Acute Medicine 4 (2014) 6e12frequent or infrequent urination, cloudy urine, and a burning
sensation during urination. Some studies have reported that
women are more prone to UTIs than men.3,4 There are several
approaches to the treatment and management of UTIs. Anti-
microbial treatment may be administered in a regimen
depending on the clinical situation. Such treatment may be
administered temporally either as a prophylactic or as a ther-
apeutic approach to treat the cause of infection. Antibiotics
such as penicillin, sulfanilamide, nitrofurantoin, and cepha-
lexin have been used for the treatment of UTIs.5 The usual
treatment for UTIs is a short course of antimicrobial drugs
such as a 3-day regimen of trimethorpimesulfamethoxazole.6
Historically, plants have served as a natural reservoir of
bioactive components with different functional groups in their
structure; their antimicrobial activity is attributed to multiple
mechanisms contributing to human health and wellbeing.7
Antimicrobial drugs derived from plants have recently
received more attention because of the increasing prevalence
of antibiotic-resistant bacteria, the escalating costs of antibi-
otic treatment, and unsatisfactory therapeutic alternatives for
recurrent UTIs. This has triggered an interest in searching for
new antimicrobial agents with diverse chemical structures and
novel mechanisms of action to treat new and re-emerging in-
fectious diseases.8
Callistemon lanceolatus DC (Myrtaceae) is an evergreen
aromatic ornamental shrub. The plant is known to possess
antibacterial, antifungal, antioxidant, antidiabetic, anti-
nociceptive, and anti-inflammatory activity.9,10 However, there
has been no previous report of antibacterial activity against
uropathogenic bacteria using C. lanceolatus seed extracts. The
aim of the work reported here was to determine the antibacterial
sensitivity of different solvent seed extracts of Clanceolatus
against isolates of various bacteria responsible for UTIs.
2. Materials and methods2.1. Collection of plant materialFresh disease-free seeds of C. lanceolatus DC were
collected from Mysore, Karnataka, India. The seeds were
washed thoroughly two to three times with running tap water
and once with sterile distilled water. The seeds were then
shade-dried on sterile blotters. A voucher specimen of this
plant material was deposited in the herbarium of the Depart-
ment of Studies in Botany, University of Mysore, Mysore,
India.2.2. Soxhlet extractionDried seeds of C. lanceolatus were powdered using a
Waring blender. Fifty grams of the powder were filled in the
thimble and extracted successively with petroleum ether,
chloroform, ethyl acetate, and methanol for 48 hours using a
Soxhlet extractor (Borosil, Mumbai). The extracts were
concentrated under reduced pressure using a rotary vacuum
evaporator. The extracts were stored in sterile amber bottles
until further use.112.3. Preliminary phytochemical screeningChemical tests were carried out on the petroleum ether,
chloroform, ethyl acetate, methanol, and also aqueous extracts
of C. lanceolatus using standard procedures to identify the
phytochemical constituents.12e142.4. Bacterial strains
2.4.1. Clinical isolates
Acinetobacter baumannii, Citrobacter freundii, Enter-
obacter aerogenes, Enterococcus faecalis, E. coli, Klebsiella
pneumoniae, methicillin-resistant Staphylococcus aureus,
Proteus mirabilis, Pseudomonas aeruginosa, Serratia mar-
cescens, and S. aureus were recovered from urine samples
obtained from the Krishna Rajendra Hospital, Mysore, Kar-
nataka, India.
The isolates obtained were identified on the basis of colony
morphology and biochemical tests.15e17
2.4.2. Preparation of inoculum
Stock cultures were maintained at 4C on slants of nutrient
agar. A loopful of stock cultures were transferred to a fresh
sterile nutrient broth tubes and incubated for 24 hours at 37C
without agitation. A 0.2-mL volume of culture was inoculated
into 5 mL of nutrient broth and incubated until it reached a
turbidity equal to a standard 0.5 McFarland solution. This is
equivalent to 106e108 CFU/mL measured spectrophotomet-
rically at 600 nm.182.5. Antibiogram assay for uropathogenic bacteriaThe antibacterial sensitivity and resistance patterns of
uropathogenic bacteria causing UTIs were detected using the
KirbyeBauer disc diffusion method.19 An aliquot of 100 mL
(0.5 McFarland equivalent) of the test bacterial inoculums
from an approximately 18e24-hour broth culture was spread
onto the surface of MuellereHinton agar media. Standard
antibiotic discs (Hi-Media, Mumbai) were placed onto the
culture lawn. The antibiotics used in this experiment were
amoxicillineclavulanic acid (30 mg), norfloxacin (10 mg),
gentamicin (10 mg), kanamycin (30 mg), trimethoprim (5 mg),
methicillin (5 mg). The plates were then incubated at 37C for
18e24 hours. Interpretation based on a comparison of the
inhibition zones with published criteria for zone diameters
were measured using Clinical and Laboratory Standards
Institute (CLSI) guidelines.2.6. Antibacterial activity of extractsThe antibacterial activity of seed extracts of C. lanceolatus
against uropathogenic bacteria was determined using a
modified KirbyeBauer disc diffusion method. A 100-mL
aliquot of bacterial suspension was swabbed uniformly onto
MuellereHinton agar plates. Volumes of 50 mL (100 mg/mL
concentration) of the petroleum ether, chloroform, ethyl ace-
tate, and methanol extracts were then loaded onto sterile 6-mm
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8 K.S. Kavitha, S. Satish / Journal of Acute Medicine 4 (2014) 6e12discs and the impregnated discs were placed on the inoculated
plates. The plates were allowed to stand at 4C for 2 hours
prior to incubation. The plates were then placed in an incu-
bator at 37C for 24 hours. The inhibition zones formed
around the disc were measured in millimeters. The assays
were performed in triplicate and the results are given as
mean  standard deviation values.19as a
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,Minimal inhibition concentration was defined as the lowest
concentration of extract required to inhibit the visible growth
of the test bacteria as indicated by 2,3,5-triphenyl tetrazolium
chloride using a microtitre enzyme-linked immunosorbent
assay plate.20 The 96 wells were filled with MullereHinton
broth media containing different test solvent extracts against
uropathogenic bacteria. Antibacterial activity was detected by
adding 0.5% 2,3,5-triphenyl tetrazolium chloride aqueous so-
lution (Merck., Mumbai); dead cells are not stained by this
solution.
3. Results
The cell morphology and results of the biochemical tests
carried out on the bacteria isolated from urine samples are
shown in Table 1. The biochemical tests for carbohydrate,
nitrogen, and oxygen metabolism, the hydrogen sulfide and
bile esculin tests, and the IMViC (indole, methyl red, Voges-
Proskauer, and citrate) test allowed the identification of the
characteristic features of the bacteria.
Table 2 gives the results of the antibiogram pattern assay
for the UTI isolates studied. The results (diameter of inhibition
zone in millimeters) were interpreted according to the CLSI
guidelines and categorized into susceptible, intermediate, and
resistant to the individual antibiotics. The antibiotics were
chosen based on the resistance of bacteria causing UTIs. The
results of the assay showed that A. baumannii was resistant to
trimethoprim and intermediate gentamicin. C. freundii
exhibited resistance towards standard antibiotics such as
amoxicillineclavulanic acid, norfloxacin, and trimethoprim
and was sensitive to gentamicin and kanamycin. E. aerogenes
showed resistance to amoxicillineclavulanic acid, kanamycin,
norfloxacin, and trimethoprim and was sensitive to genta-
micin. E. faecalis was resistant to norfloxacin. E. coli was
resistant to amoxicillineclavulanic acid, kanamycin, and
norfloxacin, showed an intermediate zone of inhibition to
gentamicin, and was sensitive to trimethoprim. K. pneumoniae
exhibited an intermediate zone of inhibition to gentamicin and
was resistant to all other test antibiotics. Methicillin-resistant
S. aureus showed resistance to all test antibiotics except
gentamicin. S. aureus was resistant to kanamycin, norfloxacin,
and trimethoprim, but sensitive to amoxicillineclavulanic
acid, gentamicin, and methicillin. P. mirabilis was sensitive to
amoxicillineclavulanic acid, gentamicin, and norfloxacin, but
was intermediate to kanamycin and resistant to trimethoprim.
P. aeruginosa exhibited resistant to kanamycin and was sen-
sitive to gentamicin and norfloxacin. S. marcescens was
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9K.S. Kavitha, S. Satish / Journal of Acute Medicine 4 (2014) 6e12resistant to only amoxicillineclavulanic acid and was sensitive
to the other test antibiotics.
Table 3 shows the presence and absence of phytochemicals
in the seed extracts of C. lanceolatus. Carbohydrates, phy-
tosterols, and saponins were present in all test solvent extracts
(petroleum ether, chloroform, ethyl acetate, methanol, and
aqueous solvent extracts), whereas alkaloids, amino acids, and
tannins in absent from all test solvent extracts. Flavonoids and
proteins were present in all test solvent extracts except for
petroleum ether. Glycosides and phenolic compounds were
present in the ethyl acetate, methanol, and aqueous extracts.
The antibacterial activity of the four different solvent seed
extracts (petroleum ether, chloroform, ethyl acetate, methanol)
were tested against 11 isolates of uropathogenic bacteria (Table
4). The zone of inhibition were interpreted on the basis of the
CLSI guidelines. All the test solvent extracts showed the least
activity against A. baumannii and methicillin-resistant S.
aureus; no inhibitory activity was observed against E. aero-
genes, P. aeruginosa, or S. marcescens. C. freundii showed the
least activity in petroleum ether, ethyl acetate, and methanol
extracts and no activity in the chloroform extract. Only the ethyl
acetate extract showed moderate activity against E. faecalis; no
zone of inhibition was observed in the other test solvent ex-
tracts. The petroleum ether and ethyl acetate extracts showed
the least activity and the methanol extract showed moderate
activity against E. coli, but no antibacterial activity in the
chloroform extract. The ethyl acetate and methanol extracts
exhibitedmoderate activity againstK. pneumoniae, whereas the
petroleum ether and chloroform extracts did not show any zone
of inhibition. Significant antibacterial activity was observed
with ethyl acetate and methanol extracts against P. mirabilis,
but only moderate activity was observed in the petroleum ether
and chloroform extracts. Significant activity against S. aureus
was observed in the petroleum ether and chloroform extracts,
but only moderate activity in the ethyl acetate and methanol
extracts. The petroleum ether extract showed the lowest mini-
mal inhibition concentration of about 5 mg/mL against all test
bacteria except P. mirabilis and S. aureus, which showed
2.5 mg/mL and 0.625 mg/mL, respectively. Similarly, the
chloroform extract showed an MIC of 5 mg/mL against A.
baumannii and methicillin-resistant S. aureus, whereas theMIC
was 2.5 mg/mL and 0.156 mg/mL against P. mirabilis and S.
aureus, respectively. The ethyl acetate and methanol extracts
showed the lowest MIC, ranging from 10 mg/mL to 1.25 mg/
mL, against the test uropathogenic bacteria.
4. Discussion
Several approaches have been taken towards the treatment
and management of UTIs. Among these, the use of botanical
agents has suggested a new way of preventing and managing
infections. Advances in phytochemistry and in the identifica-
tion of bioactive compounds from plants which are effective
against disease have renewed interest in the treatment of UTIs
by herbal medicines.
One study reported that a Vaccinium macrocarpon (cran-
berry) juice cocktail or placebo beverage intake of about
Table 3
Phytoconstituent analysis of seed extracts of Callistemon lanceolatus DC.
Sl. No. Chemical test Solvent extract of Callistemon lanceolatus DC
Petroleum ether Chloroform Ethyl acetate Methanol Aqueous
I Alkaloids
Dragendorff’s test     
Mayer’s test     
Wagner’s test     
II Carbohydrates and glycosides
Barford’s test þ þ þ þ þ
Benedict’s test þ þ þ þ þ
Fehling’s test þ þ þ þ þ
Molisch’s test þ þ þ þ þ
LibermanneBurchard’s test þ þ þ þ þ
Ligal’s test   þ þ þ
Modified Borntrager’s test þ þ þ þ þ
III Flavonoids
Alkali and acid test þ þ þ þ þ
Shinoda test  þ þ þ þ
IV Proteins and amino acids
Biuret test  þ þ þ þ
Millon’s test þ þ þ þ þ
Xanthoprotein test þ þ þ þ þ
Ninhydrin test     
V Phytosterols
LibermanneBurchard’s test þ þ þ þ þ
Terpenoids
2,4-DNPH test
þ þ þ þ þ
Anthraquinones
Borntrager’s test
þ þ þ þ þ
Steroids
Salkowski’s test
þ þ þ þ þ
VI Saponins
Foam test
þ þ þ þ þ
VII Tannins and phenolic compounds
Vanillin hydrochloric acid     
Iron (III) chloride test   þ þ þ
þ ¼ present;  ¼absent.
10 K.S. Kavitha, S. Satish / Journal of Acute Medicine 4 (2014) 6e12300 mL daily for 6 months resulted in the prevention of UTIs
in elderly women, although a dose of about 15 mL/kg had no
effect in children with neurogenic bladder dysfunction. An
intake of cranberry juice diluted with about 15 mL of water
twice daily for 4 weeks resulted in decreased bacteriuria.22
Similarly, a mixed cranberryelingonberry juice concentrate
with no added sugar, Lactobacillus rhamnosus, or no inter-
vention of about 50 mL (7.5 g cranberrye1.7 g lingonberry)
daily for 6 months, or 100 mL Lactobacillus drink 5 days per
week was reported to prevent UTIs in college-aged women.21
The administration of Arctostaphylos uva ursi with Taraxacum
officinalis UVA-E standardized extracts of uva ursi and
dandelion (Taraxacum officinalis) (oral dosage of about 3
tablets 3 times a day for 1 month followed for 1 year) had the
effect to prevent UTIs in women.21 In vivo studies of the oral
administration of berberine sulfate, an alkaloid compound
found in many plants at a concentration of 200 mg/mL for 18
hours resulted in the inhibition of fimbrial synthesis (anti-
adhesion) and direct growth inhibition of E. coli and P. aer-
uginosa. An animal study at a concentration of 200 mg/kg (1
dose) resulted in the prevention of cyclophosphamide-induced
hemorrhagic cystitis in rats.21,22The results of the work reported in this study indicate that
C. lanceolatus seed extracts show significant antibacterial
activity against S. aureus and P. mirabilis and moderate ac-
tivity against E. faecalis, E. coli, and K. pneumoniae, with
least activity against A. baumannii and C. freundii. Methanol
and acetone extracts of the leaves of C. rigidus have previ-
ously been shown to have antibacterial activity against uro-
pathogenic bacteria such as S. aureus and E. coli.23 These
workers also reported the isolation of alkaloids from the same
plant which showed significant anti-staphylococcal activity in
a UTI isolate.24 Another study using methanol extracts of the
leaves of C. lanceolatus showed the presence of carbohy-
drates, phenolic compounds, saponins, alkaloids, oils and fats,
flavonoids, phytosterols, and tannins, which also exhibited
antibacterial activity against S. aureus.25
Many reports have also been published about the biological
properties of C. lanceolatus; however, these reports are based
on the leaf components and essential oils.9,10,26e30 To the best
of our knowledge, this is the first report of a phytochemical
analysis of C. lanceolatus and determination of the antibac-
terial activity against uropathogenic bacteria of seed extracts
of C. lanceolatus. Further separation and characterization of
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assessment against the same test panel of multidrug-resistant
uropathogens would help in determining novel compounds
which could be developed into drugs.
In conclusion, the conventional use of antibiotics in the
prevention and treatment of UTIs has contributed to the devel-
opment of antibiotic-resistant uropathogens. The results ob-
tained in the work reported here might be considered sufficient
to further isolate and identify the bioactive compounds
responsible for the antibacterial activity against uropathogenic
bacteria of C. lanceolatus and to evaluate its pharmaceutical
significance. The use of these alternative strategies in the control
of UTIs could circumvent the risk of bacteriuria and microbial
drug resistance induced by the overuse of antibiotics.
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